Wnt signaling in osteoblasts and bone diseases-Reference-Cited by-全球学者库

Wnt signaling in osteoblasts and bone diseases

Published:2004-10 Issue: Volume:341 Page:19-39
ISSN:0378-1119
Container-title:Gene
language:en
Short-container-title:Gene

Author:

Westendorf Jennifer J.,Kahler Rachel A.,Schroeder Tania M.

Publisher

Elsevier BV

Subject

Genetics,General Medicine

Reference219 articles.

1. Beta-catenin is a target for the ubiquitin–proteasome pathway;Aberle;EMBO J.,1997

2. Recessive Robinow syndrome, allelic to dominant brachydactyly type B, is caused by mutation of ROR2;Afzal;Nat. Genet.,2000

3. Glycogen synthase kinase-3: properties, functions, and regulation;Ali;Chem. Rev.,2001

4. TGF-beta-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation;Alliston;EMBO J.,2001

5. Potentiation of wnt signaling by activation of the nongenotropic function of the estrogen receptor in osteoblastic cells. American Society for Bone and Mineral Research;Almeida;J. Bone Miner. Res.,2003

Cited by 657 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene variants for the WNT pathway are associated with severity in periodontal disease;Clinical Oral Investigations;2024-02-06

2. Role of 18F-NaF PET/CT in bone metastases;The Quarterly Journal of Nuclear Medicine and Molecular Imaging;2023-12

3. Exploring the Anti-Osteoporotic Potential of Daucosterol: Impact on Osteoclast and Osteoblast Activities;International Journal of Molecular Sciences;2023-11-17

4. Skeletal defects and bone metabolism in Noonan, Costello and cardio-facio-cutaneous syndromes;Frontiers in Endocrinology;2023-10-27

5. Cellular senescence in skeletal disease: mechanisms and treatment;Cellular & Molecular Biology Letters;2023-10-27